银休特 PODD 深 沪
已收盘 08-07 16:00:00 美东时间
141.17
+1.870
+1.34%
华盛通- 最 高170.99
- 今 开139.00
- 成交量 153.60万股
- 最 低 126.40
- 昨 收 139.30
- 总市值 978.87万
- 52周最高 354.88
- 市盈率 静 576.20
- 换手率 2215.21%
- 52周最低 126.40
- 委 比 71.09%
- 总股本 6.93万
- 历史最高 354.88
- 量 比 0.54
- 振 幅 32.01%
- 历史最低 1.10
- 每 手 1
- 风险率 69.40%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多FDA Classifies Insulet Omnipod Recall as Serious After Injury Reports
FDA classified Insulet's Omnipod pod recall as Class I after reports of insulin under-delivery linked to 24 serious injuries.
07-07 01:36
Insulet Boosts 2026 Outlook Fueled By Strong Omnipod Growth
Insulet (PODD) beats Q1 expectations with $1.42 EPS and $761.7M revenue. Omnipod growth drives a raised 2026 sales outlook. Read more.
05-06 20:13
Diabetes Focused MiniMed Recovery Story Builds As Pipeline Improves
MiniMed shows improved pipeline and valuation upside as insulin pump adoption grows despite rising competition and past share losses.
04-01 22:15
Diabetes-Focused Insulet Forecasts Strong 2026 Growth, Stock Soars
Insulet's stock rises 9% after beating Q4 earnings and offering strong 2026 guidance.
02-19 02:57
Earnings Scheduled For November 6, 2025
Companies Reporting Before The Bell • Clear Channel Outdoor (NYSE:CCO) is expec...
2025-11-06 19:12
医疗器械公司Insulet创2007年IPO以来新高
美股周五尾盘，美国创新医疗器械公司Insulet （PODD）最高上涨至341.14美元，创下自2007年2月首次公开募股以来的历史新高。 海量资讯、精准解读，尽在新浪财经APP 责任编辑：张俊 SF065
2025-08-30 03:51
关税乌云压顶！巴克莱点名美股医疗器械行业“抗压王”与“重灾区”
巴克莱银行在一份研究报告中分析了特朗普政府新关税政策对医疗器械行业的影响，报告指出，雅培(ABT.US)和百特国际(BAX.US)将是受影响最小的公司之列，而强生(JNJ.US)和美敦力(MDT.US)则会是受影响最大的公司。 巴克莱分析师表示，在大型医疗科技公司中，雅培、百特国际、爱德华生命科学(EW.US)和直觉外科公司(ISRG.US)等公司(“增持”评级)，以及齐默巴奥米特控股(ZBH.US)(“减持”评级)都是受关税影响最小的公司。 同样，根据这家研究经纪公司的分析师的观点，在中小盘股领域，Globus Medical(GMED.US)、阿尔法泰克(ATEC.US)和Tandem D...
2025-04-17 11:49
Analyst Expectations For Insulet's Future
Insulet (NASDAQ:PODD) underwent analysis by 5 analysts in the last quarter, rev...
2024-09-18 03:00
Piper Sandler Maintains Overweight on Insulet, Raises Price Target to $285
Piper Sandler analyst Matt O'Brien maintains Insulet (NASDAQ:PODD) with a Overweight and raises the price target from $230 to $285.
2024-09-17 19:50
Upstart, Insulet And 2 Other Stocks Executives Are Selling
The Nasdaq 100 closed higher by over 400 points during Wednesday's session. Inv...
2024-09-12 19:44
